BrightEdge
Impact investorAtlanta · Seed–Late Stage · 1 people tracked
Investment thesis
BrightEdge is the venture fund affiliated with the American Cancer Society, backing early-stage companies working on oncology therapeutics, diagnostics, devices, and related technologies. Founded in 2018 and headquartered in Atlanta, Georgia, it pursues both financial returns and mission-driven goals such as reducing disparities in cancer care. Its portfolio activity spans seed through later-stage rounds, including Series A, B, and D investments.
Source: firm website, verified Aug 7, 2026.
Team · 1 people
from the firm's website
What they invest in
from 2 of 4 portfolio companiesHealthtech ×2Biotech ×1Deep Tech ×1Impact & Social Good ×1
HQs:United States×1
Investments · 4 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 13 dated
The American Cancer Society is a nonprofit cancer-fighting organization that combats cancer through advocacy, research, and patient support.
HealthtechImpact & Social Good
Co-investorsBlue Ledge CapitalFred Hutchinson Cancer Research Center
TippingPoint Biosciences is a therapeutics company developing a drug discovery platform that targets unstructured regions in chromatin proteins to treat diseases caused by dysfunctional genome chromatin packaging, with a focus on cancer.
BiotechDeep TechHealthtechSan Francisco, US
Laura Hsieh(Founder & CEO)in
Co-investorsFREEFLOW
Frequently asked questions
- What stage does BrightEdge invest at?
- BrightEdge invests at the Seed, Series A, Series B, Late Stage stages.
- What sectors does BrightEdge focus on?
- BrightEdge focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
- Where is BrightEdge located?
- BrightEdge is headquartered in Atlanta, US.
Images
Similar investors
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
The JDRF T1D Fund is a venture philanthropy investor focused on type 1 diabetes (T1D), backing companies developing disease-modifying therapies and cures for the condition.
Gilde Healthcare is a specialist investment firm managing healthcare and climate-focused funds across venture & growth, and private equity strategies with a transatlantic team of sector specialists.